High levels of CD123 (IL3-R alpha chain) expression in immature HSPCs (CD34+/CD38−) has been reported in high-risk, but not lower-risk MDS (Xie et al., 2010; Li et al., 2014). Here, CD34 is linked to myelodysplastic syndrome.